Key result
Beta-1-selective beta-blocker use was independently associated with worse incidental learning in patients with coronary artery disease without dementia.
Why the study?
Does beta-1-selective beta-blocker use affect cognitive function in patients with coronary artery disease without dementia?
Does beta-1-selective beta-blocker use affect cognitive function in patients with coronary artery disease without dementia?
In patients with coronary artery disease without dementia, the use of beta-1-selective beta-blockers is associated with worse incidental learning.
May link beta-1-selective beta-blockers to subtle cognitive effects in CAD; hypothesis-generating and should not yet change practice.
The association between current beta-1-selective beta-blocker use and cognitive function was evaluated in 722 patients with coronary artery disease without dementia. Beta-1-selective beta-blocker use was associated with worse incidental learning independently of sociodemographic characteristics, clinical coronary artery disease severity, and depression/anxiety.
No takes yet. Share an insight, caveat, or question.
Burkauskas et al. (2015) studied this question. Beta-1-selective beta-blocker use was independently associated with worse incidental learning in patients with coronary artery disease without dementia.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: